Evidence-based articles for the informed patient and caregiver - bridging the gap between PubMed abstracts and actionable knowledge. No false hope, no despair. Clear-eyed precision.
Your glioblastoma MRI report is written for radiologists, not patients. This guide decodes the most common radiology terms - contrast enhancement, FLAIR, necrosis, midline shift, and pseudoprogression - in plain language you can use at your next appointment.
Laser interstitial thermal therapy (LITT) offers a minimally invasive surgical option for selected patients with recurrent glioblastoma whose tumors are deep-seated or whose prior radiation limits make re-irradiation unsafe. This guide compares LITT and re-irradiation, explains who tends to qualify, and outlines what the evidence actually shows.
A new area of brightness on your MRI after glioblastoma treatment may be radiation necrosis, not tumor recurrence - but standard scans often cannot tell the difference. This guide explains the biology, the advanced imaging tools that can separate the two, and how to access specialist evaluation if your local team is uncertain.
Sleep disruption affects more than 60% of glioblastoma patients, yet it rarely gets the clinical attention it deserves. This article explains why treatment - from steroids to radiation to tumor biology - disrupts sleep, and which evidence-based strategies may help.
After the first adjuvant chemotherapy cycle, MRI results can mislead and blood counts only tell part of the story. This guide explains how oncologists measure glioblastoma response, what pseudoprogression means for your scan, and when an independent second opinion is the right next step.
Temozolomide causes predictable side effects - nausea, low blood counts, fatigue, and infection risk - that can be managed with the right strategies. This guide explains what to expect at each phase of treatment and what to do when something goes wrong.
A remote second opinion can verify your GBM diagnosis and treatment plan without a single flight. This guide covers the eight documents to gather, how to send them securely, and what to expect from the virtual review.
When glioblastoma returns, re-irradiation may extend survival for selected patients. This article compares hypofractionated stereotactic radiotherapy, stereotactic radiosurgery, and brachytherapy - how they work, who qualifies, and what the evidence shows.
A glioblastoma second opinion is not a sign of doubt in your medical team - it is a standard step that changes treatment plans far more often than most patients expect. Learn exactly when to seek one, what a specialist team reviews, and how to move quickly without losing treatment time.
Personalized tumor vaccines for recurrent glioblastoma are built from your own tumor's genetic mutations and designed to train your immune system to attack those specific cancer cells. Learn how the three main vaccine types work, which clinical trials may match your molecular profile, and what testing reveals about your candidacy.